⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
IAVI to Advance Vaccine Candidate for Bundibugyo Virus, Receives Funding from CEPI
accessnewswire.com
MRK
2026 Meijer LPGA Classic for Simply Give Brings Back Fan-Favorite Family Experiences
prnewswire.com
MRK
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
accessnewswire.com
MRNA
MRK
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC USA - English APAC - English APAC - Traditional Chinese
prnewswire.com
MRK
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)
businesswire.com
MRK
Phanes Therapeutics Announces Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting
prnewswire.com
MRK
Form 8-K
sec.gov
MRK
Global Battery Materials Appoints Former Samsung Executive Dr. Yi Hyon Paik as Technical Advisor
prnewswire.com
DOW
MRK
Global Times: China’s 15th Five-Year Plan ushers in new chapter for Africa partnership: AU envoy
globenewswire.com
TSLA
NVDA
HPE
IBM
GOOG
MSFT
AMZN
INTC
AMD
MU
QCOM
AAPL
PFE
MRK
JNJ
LLY
BMY
Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
KURA
BMY
IPHA
MRK
MNPR
JAZZ
MOLN
LLY
GSK
AGEN
PFE